Catalyst Pharmaceuticals, Inc. (CPRX)
收市後：
| 前收市價 | 15.12 |
| 開市 | 14.82 |
| 買盤 | 14.67 x 300 |
| 賣出價 | 14.73 x 200 |
| 今日波幅 | 14.59 - 15.01 |
| 52 週波幅 | 11.09 - 17.77 |
| 成交量 | |
| 平均成交量 | 1,344,224 |
| 市值 | 1.732B |
| Beta 值 (5 年，每月) | 0.88 |
| 市盈率 (最近 12 個月) | 23.30 |
| 每股盈利 (最近 12 個月) | 0.63 |
| 業績公佈日 | 2024年5月08日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 26.71 |
Insider MonkeyJim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. Jim Cramer kicked off 2024 with a positive note for the healthcare sector, saying in a program in January that the […]
ZacksWhy Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
InvestorPlace3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
Biotech has seen its fair share of ups and downs, including a massive surge during the pandemic followed by a considerable dip. However, the industry will never go too far away from center stage as diseases and conditions will always need medicine and technology to treat them. These three strong buy biotech stocks are joining the upper ranks of their industry with promising new drugs and encouraging financials that justify serious consideration. Given the timeline of clinical trials and new rele
